Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 901–920 of 1,000 recalls
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Sigan Industries Group Inc.
Chemical Contamination: Presence of benzene
Amgen, Inc.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.